If claiming for a Documented Loss Cash Payment for the AT&T 1 Data Incident and a Documented Loss Cash Payment for the AT&T 2 ...
In the study, Raza and colleagues reviewed data from 214 adults who underwent BLVR at a single center between January 2018 ...
Rhythm Pharmaceuticals (RYTM) announced that Rhythm and its partners delivered four Rhythm data presentations at ObesityWeek 2025, held last week ...
As neural implant technology and A.I. advance at breakneck speeds, do we need a new set of rights to protect our most ...
New biomarker and immune data presented at the Society for Immunotherapy of Cancer (SITC) 2025 Annual MeetingFollowing the recent presentation of unprecedented two-year clinical efficacy data from the ...
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that ...
In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel therapies to manage inflammation, lipids, hypertension, obesity, diabetes and ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q3 2025 Earnings Call Transcript November 12, 2025 Acumen Pharmaceuticals, Inc.
Ottawa Citizen on MSN
Ottawa police budget calls for increase of five per cent
The Ottawa Police Service tabled its draft budget with a five-per-cent increase that Chief Eric Stubbs said was necessary to ...
In an analysis comparing bariatric surgery vs. obesity drugs in patients with diabetes and obesity, surgery was tied to lower ...
Washington State University (WSU) is undergoing a significant system-wide redesign aimed at modernizing its campuses and ...
EXCLUSIVE: When actress and technologist Eline Van der Velden sat down for a Deadline-moderated panel at the Zurich Summit in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback